Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
The Journal of Infectious Diseases|July 19, 2024
Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical TrialKara W Chew, Babafemi O Taiwo, Carlee Moser, et al.
Open Forum Infectious Diseases|July 2, 2025
Implementation of an Online Drug-Drug Interaction Screener for the STRIVE Ensitrelvir Trial for COVID-19Joshua P Havens, Nayon Kang, Lucy Chung, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 14, 2019
Impact of Integrase Inhibition Compared With Nonnucleoside Inhibition on HIV Reservoirs in Lymphoid TissuesMeghan Rothenberger, Krystelle Nganou-Makamdop, Cissy Kityo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled TrialAnne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
AIDS (London, England)|April 8, 2021
Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settingsTanakorn Apornpong, Beatriz Grinsztejn, Michael Hughes, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19: A Phase 2 Randomized Clinical TrialKara W Chew, Carlee Moser, Eric S Daar, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2015
Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruptionMeghan K Rothenberger, Brandon F Keele, Stephen W Wietgrefe, et al.
JCI Insight|August 8, 2024
Effect of metabolic status on response to SIV infection and antiretroviral therapy in nonhuman primatesGabriela M Webb, Kristin A Sauter, Diana Takahashi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2021
Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose RifapentineAnthony T Podany, Michelle Pham, Erin Sizemore, et al.
JAMA Network Open|March 16, 2022
Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury: A Randomized Clinical TrialMichael A Puskarich, Nicholas E Ingraham, Lisa H Merck, et al.
Pageof 17